Ikarian Capital, LLC Vascular Biogenics Ltd. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.22 - $1.95 $902 - $1,443	-740 Reduced 0.09%	830,007 $1.34 Million
Q1 2022 May 13, 2022	BUY	$1.15 - $1.97 $45,895 - $78,620	39,909 Added 5.05%	830,747 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$1.94 - $2.55 $19,347 - $25,431	-9,973 Reduced 1.25%	790,838 $1.62 Million
Q1 2021 May 17, 2021	BUY	$1.79 - $2.91 $1.43 Million - $2.33 Million	800,811 New	800,811 $1.6 Million

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.